Metastatic Bladder Cancer Surgery: Types, Benefits, and Risks - Everyday Health
Metastatic Bladder Cancer Surgery: Types, Benefits, and Risks Everyday Health
Bladder Cancer News
Navigating Bladder Cancer: Team-Based Care and Clinical Trials - Cure Today
Navigating Bladder Cancer: Team-Based Care and Clinical Trials Cure Today
NIAGARA Trial Explores Urinary Tumor DNA as a Biomarker in Bladder Cancer - Michiel Van Der Heijden - UroToday
NIAGARA Trial Explores Urinary Tumor DNA as a Biomarker in Bladder Cancer - Michiel Van Der Heijden UroToday
Transdermal therapy restores anti-tumor immunity in bladder cancer models - Drug Discovery News
Transdermal therapy restores anti-tumor immunity in bladder cancer models Drug Discovery News
A Urine Test That Could Change the Course of Bladder Cancer Care - Stanford Medicine
A Urine Test That Could Change the Course of Bladder Cancer Care Stanford Medicine
What Role Will The EV-304 Regimen Occupy in The Bladder Cancer Paradigm? - CancerNetwork
What Role Will The EV-304 Regimen Occupy in The Bladder Cancer Paradigm? CancerNetwork
Pembrolizumab plus chemoradiation shows feasibility in muscle-invasive bladder cancer - Urology Times
Pembrolizumab plus chemoradiation shows feasibility in muscle-invasive bladder cancer Urology Times
Use of Local Therapy After EV-Pembro in Advanced Bladder Cancer “Striking” - Oncology News Central
Use of Local Therapy After EV-Pembro in Advanced Bladder Cancer “Striking” Oncology News Central
Neoadjuvant Sacituzumab Govitecan Plus Pembrolizumab Shows Activity in MIBC - Renal and Urology News
Neoadjuvant Sacituzumab Govitecan Plus Pembrolizumab Shows Activity in MIBC Renal and Urology News
Running Influencer, 45, Dies of Cancer 3 Days After Getting Married - People.com
Running Influencer, 45, Dies of Cancer 3 Days After Getting Married People.com
Cosmetologist Bladder Cancer Lawsuit Alleges Hair Dye Exposure Risks Withheld From Salon Workers - AboutLawsuits.com
Cosmetologist Bladder Cancer Lawsuit Alleges Hair Dye Exposure Risks Withheld From Salon Workers AboutLawsuits.com
Doctors Say This Is the Number-1 Sign of Bladder Cancer - Prevention
Doctors Say This Is the Number-1 Sign of Bladder Cancer Prevention
Blood Test Predicts Which Bladder Cancer Patients May Safely Skip Surgery - Fox Chase Cancer Center
Blood Test Predicts Which Bladder Cancer Patients May Safely Skip Surgery Fox Chase Cancer Center
Personalizing Therapy Duration in Bladder Cancer - Cure Today
Personalizing Therapy Duration in Bladder Cancer Cure Today
Clinical Practice Updates: Navigating the New Standard of Care in Bladder Cancer - Oncology Nursing News
Clinical Practice Updates: Navigating the New Standard of Care in Bladder Cancer Oncology Nursing News
ctDNA-Guided Adjuvant Atezolizumab in Muscle-Invasive Bladder Cancer - NEJM
ctDNA-Guided Adjuvant Atezolizumab in Muscle-Invasive Bladder Cancer NEJM
Early Access Program for Cretostimogene Opens Enrollment in BCG-Unresponsive Bladder Cancer - Sarah Psutka - UroToday
Early Access Program for Cretostimogene Opens Enrollment in BCG-Unresponsive Bladder Cancer - Sarah Psutka UroToday
First-Line Treatment Options for Advanced Urothelial Carcinoma - Everyday Health
First-Line Treatment Options for Advanced Urothelial Carcinoma Everyday Health
Study finds link between colorblindness and death from bladder cancer - Stanford Medicine
Study finds link between colorblindness and death from bladder cancer Stanford Medicine
A Decade of Progress in Bladder Cancer Treatment - Cure Today
A Decade of Progress in Bladder Cancer Treatment Cure Today
Mayo Clinic expert highlights improved survival in muscle-invasive bladder cancer and kidney cancer - Mayo Clinic News Network
Mayo Clinic expert highlights improved survival in muscle-invasive bladder cancer and kidney cancer Mayo Clinic News Network
Colour blindness as a risk factor for bladder cancer - Nature
Colour blindness as a risk factor for bladder cancer Nature
Bladder Cancer Therapy Enfortumab Vedotin (Padcev) Approved by FDA for More Patients - Memorial Sloan Kettering Cancer Center
Bladder Cancer Therapy Enfortumab Vedotin (Padcev) Approved by FDA for More Patients Memorial Sloan Kettering Cancer Center
Bladder Preservation Strategies in Muscle-Invasive Bladder Cancer - ASCO Publications
Bladder Preservation Strategies in Muscle-Invasive Bladder Cancer ASCO Publications
New drug developed at UC Davis offers hope to bladder cancer patients - University of California - Davis Health
New drug developed at UC Davis offers hope to bladder cancer patients University of California - Davis Health
Yale Launches Innovative Clinical Trial for Metastatic Bladder Cancer - Yale School of Medicine
Yale Launches Innovative Clinical Trial for Metastatic Bladder Cancer Yale School of Medicine
Hypoxia-inducible factor 1α exerts dual roles in bladder cancer progression through TIMP3-mediated regulation of angiogenesis and invasion | Scientific Reports - Nature
Hypoxia-inducible factor 1α exerts dual roles in bladder cancer progression through TIMP3-mediated regulation of angiogenesis and invasion | Scientific Reports Nature
A multi-modal approach for decision making in bladder cancer - Nature
A multi-modal approach for decision making in bladder cancer Nature
CystoDS: a multiclass endoscopy image dataset for artificial intelligence-assisted bladder cancer detection - Nature
CystoDS: a multiclass endoscopy image dataset for artificial intelligence-assisted bladder cancer detection Nature
Mount Sinai Study May Help Cancer Patients Keep Their Bladder - Mount Sinai
Mount Sinai Study May Help Cancer Patients Keep Their Bladder Mount Sinai
Low-grade non-muscle-invasive bladder cancer: molecular landscape, treatment strategies and emerging therapies - Nature
Low-grade non-muscle-invasive bladder cancer: molecular landscape, treatment strategies and emerging therapies Nature
New Survey Reveals Non-Muscle Invasive Bladder Cancer Patients Seek More Care Conversations - ImmunityBio
New Survey Reveals Non-Muscle Invasive Bladder Cancer Patients Seek More Care Conversations ImmunityBio
Mount Sinai Study Identifies Inflammatory Immune Pathway Driving Immunotherapy Resistance in Bladder Cancer - Mount Sinai
Mount Sinai Study Identifies Inflammatory Immune Pathway Driving Immunotherapy Resistance in Bladder Cancer Mount Sinai
Bladder Cancer Remission Rate: What Patients Need to Know in 2025 - Oncodaily
Bladder Cancer Remission Rate: What Patients Need to Know in 2025 Oncodaily
BNCT for Bladder Cancer: Systemic or Intravesical? - Bioengineer.org
BNCT for Bladder Cancer: Systemic or Intravesical? Bioengineer.org
Outcomes of sequential therapy for advanced upper tract urothelial cancer and bladder cancer - Nature
Outcomes of sequential therapy for advanced upper tract urothelial cancer and bladder cancer Nature
HER2 in Bladder Cancer: A Frequent but Complex and Dynamic Biomarker - Daniele Raggi - UroToday
HER2 in Bladder Cancer: A Frequent but Complex and Dynamic Biomarker - Daniele Raggi UroToday
Groundbreaking Advances for Patients with Muscle-Invasive Bladder Cancer and More to Come - Memorial Sloan Kettering Cancer Center
Groundbreaking Advances for Patients with Muscle-Invasive Bladder Cancer and More to Come Memorial Sloan Kettering Cancer Center
Bladder Cancer: What You Need to Know - University of Colorado Anschutz
Bladder Cancer: What You Need to Know University of Colorado Anschutz
Advances in the management of localized bladder cancers - Nature
Advances in the management of localized bladder cancers Nature